Buffers in Biologics Manufacturing

BioProcess International

By Jennifer Bratt, Angela Linderholm, G. David Green, and Steve M. Chamow

View article here.

February 2017

ANGUS Life Sciences is featured in the February issue of BioProcess International. The article "Buffers in Biologics Manufacturing" discusses the importance of understanding the variables involved in selecting the right buffer and buffer supplier to ensure success in biomanufacturing processes.



About ANGUS Chemical Company

ANGUS Chemical Company (“ANGUS”) is a specialty and fine chemical company dedicated to the development of novel chemistry that helps customers deliver enhanced product and process performance. ANGUS is committed to constantly improving products and services by mastering science and technology. The company innovates through its unique nitroalkane chemistry, which harbors the reactivity to create complex molecules for use in a wide variety of applications. The innate characteristics of this chemistry enable multifunctional additives which improve performance, reduce reaction steps and cut synthesis costs.


About Golden Gate Capital

Golden Gate Capital is a San Francisco-based private equity investment firm with approximately $12 billion of capital under management. Golden Gate Capital is dedicated to partnering with world-class management teams to invest in change-intensive, growth businesses. The firm targets investments where there is a demonstrable opportunity to significantly enhance a company’s value. The principals of Golden Gate Capital have a long and successful history of investing with management partners across a wide range of industries and transaction types. Other notable mining and industrials investments sponsored by Golden Gate Capital include US Silica, EP Minerals, ArrMaz, Humanetics Innovative Solutions, Springs Window Fashions, Canada Fluorspar Inc. and Atrium Windows. For more information, visit www.goldengatecap.com.


Media for ANGUS Chemical Company:

Scott C. Johnson
+1 847-808-3769
scjohnson@angus.com


Media for Golden Gate Capital:

Sard Verbinnen & Co
Nathaniel Garnick / Jenny Gore
212-687-8080 / 312-895-4700